While these medications are beneficial, they have potential side effects, so understanding natural ways to support GLP-1 can be empowering and sustainable
of the human body (ref.4,9,10)
Injection site reactionsincluding erythema, pruritus, or indurationoccur in approximately 2-5% of patients and typically resolve spontaneously
Compounded semaglutide and tirzepatide are not approved by the FDA and have not been evaluated for safety, effectiveness, or quality by the FDA
Funding This study was supported by grants from the Scientific Research Foundation of the Ministry of Education of China (Grant No.2021JH019) and Scientific Research Foundation of Postdoctoral Department of Heilongjiang Province (Grant No.LBH-Q21025)
While its future availability is uncertain, its anticipated to be prescribed as weekly injections, much like existing GLP-1 receptor agonists